Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan

## Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Yttrium Y 90 Ibritumomab Tiuxetan**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.